Daily Archives: December 21, 2015
GSK to Buy BMS’s HIV Portfolio
Drug giant GlaxoSmithKline has reached a deal to acquire Bristol-Myers Squibb’s HIV portfolio. GSK will pay $350 million up front and could pay an additional $1 billion depending on developmental and sales milestones. GSK did the deal through its subsidiary … Continue reading
Darren Geliebter
Mathew Lombard
THE PRINCIPAL REGISTER 